Insider Transactions in Q4 2023 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
33,334
-12.27%
|
$966,686
$29.01 P/Share
|
|
Dec 18
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,775
-2.27%
|
$44,375
$25.9 P/Share
|
|
Dec 18
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
2,088
-0.76%
|
$52,200
$25.9 P/Share
|
|
Dec 18
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,229
-3.19%
|
$30,725
$25.9 P/Share
|
|
Dec 18
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
8,165
-2.12%
|
$204,125
$25.9 P/Share
|
|
Dec 18
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,993
-2.87%
|
$74,825
$25.9 P/Share
|
|
Dec 15
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.57%
|
$130,000
$26.64 P/Share
|
|
Dec 15
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.37%
|
$20,000
$4.09 P/Share
|
|
Dec 06
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.57%
|
$125,000
$25.0 P/Share
|
|
Dec 06
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.37%
|
$20,000
$4.09 P/Share
|
|
Nov 20
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-3.75%
|
$31,500
$21.7 P/Share
|
|
Nov 09
2023
|
Thilo Schroeder |
BUY
Grant, award, or other acquisition
|
Indirect |
1,457,211
+26.06%
|
-
|
|
Nov 09
2023
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
2,091,672
+47.29%
|
-
|
|
Nov 09
2023
|
Sandra Horning |
BUY
Grant, award, or other acquisition
|
Direct |
90,487
+28.71%
|
-
|
|
Oct 25
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+6.7%
|
$0
$0.54 P/Share
|
|
Oct 24
2023
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+8.35%
|
$0
$0.49 P/Share
|
|
Oct 23
2023
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,524
+13.57%
|
$73,572
$3.39 P/Share
|
|
Oct 16
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-4.16%
|
$800,000
$32.87 P/Share
|
|
Oct 16
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.01%
|
$100,000
$4.09 P/Share
|
|
Oct 11
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,667
-5.74%
|
$483,343
$29.05 P/Share
|